Azzad Asset Management Inc /Adv Amgen Inc Transaction History

Azzad Asset Management Inc /Adv

  • $848 Billion
  • Q2 2024

A detailed history of Azzad Asset Management Inc /Adv transactions in Amgen Inc stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 6,157 shares of AMGN stock, worth $2.05 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
6,157
Holding current value
$2.05 Million
% of portfolio
0.23%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$262.75 - $319.31 $1.62 Million - $1.97 Million
6,157 New
6,157 $1.92 Billion
Q3 2023

Apr 01, 2024
SELL
$218.65 - $271.46 $1.57 Million - $1.95 Million
-7,188 Closed
0 $0
Q2 2023

Apr 01, 2024
BUY
$214.27 - $253.37 $35,568 - $42,059
166 Added 2.36%
7,188 $1.6 Billion
Q1 2023

Apr 01, 2024
BUY
$225.79 - $275.2 $21,224 - $25,868
94 Added 1.36%
7,022 $1.7 Billion
Q4 2022

Apr 01, 2024
SELL
$229.03 - $291.01 $2.11 Million - $2.68 Million
-9,217 Reduced 57.09%
6,928 $1.82 Billion
Q3 2022

Apr 01, 2024
BUY
$224.46 - $253.15 $30,302 - $34,175
135 Added 0.84%
16,145 $3.73 Billion
Q2 2022

Apr 01, 2024
BUY
$230.71 - $256.74 $2.13 Million - $2.38 Million
9,253 Added 136.94%
16,010 $3.83 Billion
Q1 2022

Apr 01, 2024
BUY
$219.27 - $242.57 $256,984 - $284,292
1,172 Added 20.98%
6,757 $1.63 Billion
Q4 2021

Apr 01, 2024
SELL
$198.88 - $227.6 $1.53 Million - $1.75 Million
-7,703 Reduced 57.97%
5,585 $1.26 Billion
Q3 2021

Apr 01, 2024
BUY
$212.27 - $248.7 $128,423 - $150,463
605 Added 4.77%
13,288 $2.83 Billion
Q2 2021

Apr 01, 2024
BUY
$233.58 - $259.14 $78,015 - $86,552
334 Added 2.7%
12,683 $3.09 Billion
Q1 2021

Apr 01, 2024
BUY
$221.91 - $258.6 $67,460 - $78,614
304 Added 2.52%
12,349 $3.07 Billion
Q4 2020

Apr 01, 2024
BUY
$216.38 - $257.67 $288,650 - $343,731
1,334 Added 12.45%
12,045 $2.77 Billion
Q3 2020

Apr 01, 2024
BUY
$234.65 - $260.95 $366,757 - $407,864
1,563 Added 17.09%
10,711 $2.72 Billion
Q2 2020

Apr 01, 2024
BUY
$197.81 - $242.74 $601,540 - $738,172
3,041 Added 49.8%
9,148 $2.16 Billion
Q1 2020

Apr 01, 2024
SELL
$182.24 - $241.7 $1.63 Million - $2.16 Million
-8,957 Reduced 59.46%
6,107 $1.24 Billion
Q4 2019

Apr 01, 2024
BUY
$189.21 - $243.2 $32,165 - $41,344
170 Added 1.14%
15,064 $3.58 Billion
Q3 2019

Apr 01, 2024
BUY
$174.11 - $208.62 $1.63 Million - $1.96 Million
9,389 Added 170.55%
14,894 $3.27 Billion
Q2 2019

Apr 01, 2024
BUY
$166.7 - $195.41 $263,052 - $308,356
1,578 Added 40.18%
5,505 $1.01 Billion
Q1 2019

Apr 01, 2024
SELL
$180.87 - $203.88 $2,170 - $2,446
-12 Reduced 0.3%
3,927 $746 Million
Q4 2018

Apr 01, 2024
BUY
$178.4 - $208.25 $702,717 - $820,296
3,939 New
3,939 $767 Million

Others Institutions Holding AMGN

# of Institutions
3,054
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email